# Amino Acid Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 16
- Latest FDA row update: 08/17/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- B. Braun Medical Inc. — Plenamine, Injection, 0.15 (NDC 0264-4500-00) — FDA availability: Available — updated: 08/07/2026
- B. Braun Medical Inc. — Plenamine, Injection, 0.15 (NDC 0264-4500-05) — FDA availability: Available — updated: 08/07/2026
- B. Braun Medical Inc. — TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) — FDA availability: Available — updated: 08/07/2026
- Baxter Healthcare — Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03) — FDA availability: Unavailable — updated: 08/17/2026
- Baxter Healthcare — Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06) — FDA availability: Available — updated: 08/17/2026
- Otsuka ICU Medical LLC — Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) — FDA availability: Available — updated: 08/17/2026
- Otsuka ICU Medical LLC — Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) — FDA availability: Available — updated: 08/17/2026
- Otsuka ICU Medical LLC — Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) — FDA availability: Unavailable — updated: 08/17/2026
- Otsuka ICU Medical LLC — Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) — FDA availability: Unavailable — updated: 08/17/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/amino-acid-injection)
- [JSON record](https://citefacts.com/shortages/amino-acid-injection.json)